Dr. Albitar has extensive experience in anatomic/clinical pathology, hematopathology, and molecular pathology. He also has extensive business and administrative experience as an executive leader of large laboratories, Board member, and director of large scientific and genomic diagnostic studies. Until recently, Dr. Albitar was the Senior Vice President, Chief Medical Officer and Director of Research and Development at NeoGenomics.
Experience
Dr. Maher Albitar is the founder and CEO of Genomic Testing Cooperative, LCA. Dr. Albitar has extensive experience in anatomic/clinical pathology, hematopathology and molecular pathology. He also has extensive business and administrative experience as an executive leader of large laboratories, Board member, and director of large scientific and genomic diagnostic studies.
-
Genomic Testing Cooperative
2018- Present
-
Senior Vice President, Chief Medical Officer and Director of Research and Development at NeoGenomics.
From 2015 - 2018
-
Medical Director for Hematopathology and Oncology, Nichols Institute, Quest Diagnostics, and Chief R&D for Hematopathology and Oncology for Quest Diagnostics.
From 2003 - 2010
Educational Background
Dr. Albitar has published more than 300 peer-reviewed papers, book chapters, and review articles. He is the lead inventor on more than 50 different patents and patent applications
-
Dr. Albitar is certified AP/CP pathologist with fellowship training in Hematopathology and molecular pathology.
-
Dr. Albitar spend 4 years in Physician/Scientist training program at the University of Pennsylvania/Howard Hughes Medical Institute and the Department of Genetics.
-
1991 to 2003, Dr. Albitar held various faculty positions at the University of Texas MD Anderson Cancer Center, including Section Chief of Leukemia Section in Laboratory Medicine and Pathology Department, Director of the molecular laboratory and Director of Hematopathology Fellowship program.
